Share:
Peer-Reviewed Publication
JACC Adv2025;4(9):102059.September 1, 2025Journal Article

Cardiovascular Sciences Research Consortium Think Tank: Remote Monitoring for Cardiac Safety in Clinical Trials.

Krishna Pundi1, Sanjeev Bhavnani2, Rosalyn Adigun3, Jose Vicente4, Rajesh Ghosh5, David Albert6, Waqaas Al-Siddiq7, Charles Benson8, Antoniu Fantana8, Jennifer C Goldsack9, Salim F Idriss10, Gregory Marcus11, Pamela Tenaerts12, Mintu P Turakhia13, Jonathan Seltzer14
1Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. Electronic address: kpundi@stanford.edu.
2Department of Cardiology, Scripps Clinic, La Jolla, California, USA.
3Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
4Translational Cures, Inc, Washington, DC, USA.
5Novartis, Cambridge, Massachusetts, USA.
6AliveCor Inc., Mountain View, California, USA.
7Biotricity, Inc, San Francisco, California, USA.
8Eli Lilly, Indianapolis, Indiana, USA.
9The Digital Medicine Society, Boston, Massachusetts, USA.
10Division of Pediatric Electrophysiology, Duke University Medical Center, Durham, North Carolina, USA.
11Division of Cardiology, University of California-San Francisco, San Francisco, California, USA.
12Medable, Inc, Palo Alto, California, USA.
13Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
14Cardiovascular Safety Research Consortium, Durham, North Carolina, USA.

Abstract

Recent advances in remote monitoring technologies have empowered continuous tracking of physiologic parameters with high accuracy and granularity. However, there are important differences in the hardware, data processing, and feedback streams of individual devices which can impact the use of digital health technologies when evaluating safety in studies. This expert panel is the result of a think t…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.